- Home
- SCTX vs LEO Comparison
SCTX vs LEO Comparison
Compare SCTX & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCTX | LEO |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.1M | 384.3M |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | SCTX | LEO |
|---|---|---|
| Price | $31.70 | $6.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 218.3K | ★ 258.0K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.01% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $155.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $5.83 |
| 52 Week High | $39.60 | $6.55 |
Technical Indicators
Market Signals| Indicator | SCTX | LEO |
|---|---|---|
| Relative Strength Index (RSI) | 62.83 | 45.73 |
| Support Level | $19.09 | $6.15 |
| Resistance Level | $39.60 | $6.27 |
| Average True Range (ATR) | 4.12 | 0.04 |
| MACD | 1.05 | 0.01 |
| Stochastic Oscillator | 66.75 | 45.83 |
Price Performance
Historical ComparisonAbout SCTX Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products include equity and fixed income mutual funds, retail money market funds, government/treasury money market funds, institutional money market funds, and others. The company and its affiliates, as well as others involved in the management, sales, investment activities, business operations, or distribution of the fund, are engaged in businesses and have interests other than those of managing the fund.